Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07897409Phase 2Not Yet Recruiting
The Impact of Using Nicorandil for the Prevention of Doxorubicin-Induced Cardiotoxicity
DoxorubicinDoxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy+1 more
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Nur H Md, lecturer

Universiti Sains Malaysia

Moderately Similar
1 trials

Shared therapeutic areas:

DoxorubicinDoxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy+1 more

Worked with same sponsors:

Universiti Sains Malaysia
Collaborated on 1 trial
Similarity Score44%

Noha S Abdelaziz, PhD

Universiti Sains Malaysia

Moderately Similar
1 trials

Shared therapeutic areas:

DoxorubicinDoxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy+1 more

Worked with same sponsors:

Universiti Sains Malaysia
Collaborated on 1 trial
Similarity Score44%

Ayman A G, Prof

National Cancer Institute (NCI)

Moderately Similar
1 trials

Shared therapeutic areas:

DoxorubicinDoxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy+1 more

Worked with same sponsors:

Universiti Sains Malaysia
Collaborated on 1 trial
Similarity Score44%

Yufu Li

Henan Cancer Hospital

Related
1 trials

Shared therapeutic areas:

Doxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy
Similarity Score15%

Hui Zhou

Hunan Cancer Hospital

Related
1 trials

Shared therapeutic areas:

Doxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy
Similarity Score15%

Hesheng He

The First Affilaited Hospital of Wannan Medical College

Related
1 trials

Shared therapeutic areas:

Doxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy
Similarity Score15%

Hongmei Jing

Peking University Third Hospital

Related
4 trials

Shared therapeutic areas:

Doxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy
Similarity Score15%

Xiaojia Wang

Zhejiang Cancer Hospital

Related
2 trials

Shared therapeutic areas:

Doxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy
Similarity Score15%

Zhenchang Sun

The First Affiliated Hospital of Zhengzhou University

Related
1 trials

Shared therapeutic areas:

Doxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy
Similarity Score15%

Jiwei Liu

The First Affiliated Hospital of Dalian Medical University

Related
2 trials

Shared therapeutic areas:

Doxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07897409Phase 2PrincipalInvestigator

The Impact of Using Nicorandil for the Prevention of Doxorubicin-Induced Cardiotoxicity

DoxorubicinDoxorubicin Adverse ReactionDoxorubicin Induced Cardiomyopathy+1 more
Not Yet Recruiting

All 1 trials loaded